PRMT6 gene knock-down (KD) results in a p21 derepression in breast cancer cells, which is p53-independent, and leads to cell cycle arrest, cellular senescence and reduced growth in soft agar assays, and severe combined immune deficiency (SCID). The gene discussed is CDKN1A; the disease is breast carcinoma.